Case Report
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Apr 27, 2020; 12(4): 170-183
Published online Apr 27, 2020. doi: 10.4254/wjh.v12.i4.170
Inflammatory myofibroblastic tumor of the liver: A case report and review of literature
Alexandra Filips, Martin H Maurer, Matteo Montani, Guido Beldi, Anja Lachenmayer
Alexandra Filips, Guido Beldi, Anja Lachenmayer, Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland
Martin H Maurer, Department of Radiology, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland
Matteo Montani, Institute of Pathology, Inselspital, University Hospital, University Bern, Bern 3010, Switzerland
Author contributions: Filips A reviewed the literature and contributed to manuscript drafting; Filips A, Maurer MH, Montani M, Beldi G and Lachenmayer A were responsible for the revision of the manuscript for important intellectual content; all authors issued final approval for the version to be submitted.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Anja Lachenmayer, MD, PhD, Doctor, Surgeon, Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, Bern 3010, Switzerland. anja.lachenmayer@insel.ch
Received: November 29, 2019
Peer-review started: November 29, 2019
First decision: December 12, 2019
Revised: February 14, 2020
Accepted: March 11, 2020
Article in press: March 11, 2020
Published online: April 27, 2020
Core Tip

Core tip: In summary of the literature and with the experience from our own recent case, complete surgical resection of suspected inflammatory myofibroblastic tumors of the liver should be the preferred treatment of choice in order to rule out malignancy, avoid long-term medical treatment and to be able to recommend an appropriate follow-up for the patient.